Renal Cell Carcinoma
Springer-Verlag New York Inc.
978-1-4899-9139-3 (ISBN)
Preface.- The Genetic Basis of Kidney Cancer and Implications for Targeted Therapies.- Molecular Biology of Clear Cell Renal Carcinoma.- HIF Biology in RCC: Implications for Signaling, Disease Progression, and Treatment.- Tissue Biomarkers in Renal Cell Carcinoma: Intermediate Endpoints in the Selection of Targeted Agents for RCC.- Molecular Characterization of Renal Cell Carcinoma.- Targeting The Vegf Pathway In Renal Cell Carcinoma.- Angiopoetins and Other Non-VEGF Antiangiogenic Targets In Advanced Renal Cell Carcinoma.- Towards Personalized Cancer Medicine.- Epigenetic Targeting and Histone Deacetylase Inhibition in RCC.- C-MET as a Novel Target for the Treatment of Renal Cell Carcinoma.- Characterizing and Modulating the Tumor Micro-Environment in Renal Cell Carcinoma: Potential Therapeutic Strategies.- Carbonic Anhydrase IX: Its role as a biomarker, diagnostic, and therapeutic target in Renal Cell Carcinoma.- Presurgical Therapy for Renal Cell Carcinoma and Implications for Window of Opportunity Trials.- Mechanisms of Resistance to VEGF Directed Therapy and Implications for Future Trial Design.- Vaccine Based Immunotherapy and Targeting the Tumor Microenvironment in Renal Cell Carcinoma.- Index.
Zusatzinfo | 10 Tables, black and white; XII, 328 p. |
---|---|
Verlagsort | New York |
Sprache | englisch |
Maße | 155 x 235 mm |
Gewicht | 522 g |
Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Nephrologie |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie | |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie | |
Medizin / Pharmazie ► Studium | |
Schlagworte | carcinoma • Prognostic • Renal • Renal Cell • Therapeutic |
ISBN-10 | 1-4899-9139-5 / 1489991395 |
ISBN-13 | 978-1-4899-9139-3 / 9781489991393 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich